Edition:
United Kingdom

Oramed Pharmaceuticals Inc (ORMP.OQ)

ORMP.OQ on NASDAQ Stock Exchange Capital Market

7.38USD
20 Apr 2018
Change (% chg)

$0.23 (+3.29%)
Prev Close
$7.14
Open
$7.11
Day's High
$7.38
Day's Low
$7.11
Volume
2,250
Avg. Vol
6,241
52-wk High
$11.34
52-wk Low
$6.19

Select another date:

Tue, Feb 20 2018

BRIEF-Oramed Pharmaceuticals' Unit Enters Clinical Research Organization Services Agreement With Integrium

* SAYS ON FEB 14, A UNIT ENTERED CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT WITH INTEGRIUM EFFECTIVE AS OF NOV 1, 2017‍​

BRIEF-Oramed receives approval for clinical study to treat NASH

* Oramed receives regulatory approval to conduct clinical study for treatment of NASH with its oral insulin capsule

Select another date: